Background: Since 1996, the Swedish National Diabetes Register (NDR) enabled health care providers to monitor their clinical performance over time and compare it with the national average. All health systems of Swedish county councils report data. By 2014, the NDR included data from 360 000 patients. Comparisons among county councils show significant variations in clinical outcomes and in adherence to evidence-based national guidelines. The purpose of this study was to evaluate whether and how a quality improvement collaborative could influence clinical practice and outcomes. Methods: Twenty-three diabetes teams from all over Sweden, both primary care units and internal medicine departments, joined a quality improvement collaborative. The project was inspired by the Breakthrough Collaborative Model and lasted for 20 months. Evaluation data were collected from the teams' final reports and the NDR throughout the study period. Results and Conclusion: The teams reported improved patient outcomes significantly compared with the national average for systolic blood pressure and low-density lipoprotein levels. In contrast, glycated hemoglobin A 1c levels deteriorated in the whole NDR population. Five themes of changes in practice were tested and implemented. Success factors included improved teamwork, with active use of register data, and testing new ideas and learning from others.
care prompted the Swedish Association for Diabetology to create the National Diabetes Register (NDR; available at: https://www.ndr.nu), a quality register for improvement, in 1996.
In 2014, Sweden had about 100 National Quality Registers (NQRs; available at: http://www.kvalitetsregister .se). These registers contain individual patient data (based on personal identification numbers) regarding process and outcome indicators for a wide range of conditions. In addition to supporting local improvement efforts, they are used for national open comparisons of the performance of county councils and, sometimes, individual hospitals. 2 The vision for NQRs is that they will be "used in an integrated and active way for continuous learning, improvement, research and management to create the best possible health and care together with the individual." 3 Since quality indicators are essential in improvement efforts, 4, 5 there is a largely untapped potential to use these NQRs for systematic improvement in daily work.
In an effort to reduce morbidity and mortality from DM, the NDR was designed to allow comparisons of a number of clinical variables among units that care for patients with DM. 6 Developments have been rapid, especially as health care providers have improved their understanding of the various risk factors relevant to diabetic complications and cardiovascular disease and harnessed the value of modern therapies to address blood glucose, blood pressure, and blood lipids. By 2014, the NDR contained data from approximately 360 000 patients, which equals 90% of all patients in Sweden with DM, based on an estimated diabetes prevalence of 4%. 7 The vast majority of health care providers use the NDR; it is used by more than 95% (n = 90) of all internal medicine departments (IDMs) and 95% (n = 1178) of primary care units (PCUs) in Sweden. NDR reports indicate significant differences between clinic and county council health systems in Sweden for both process and outcome measures. There is a substantial gap between guidelines for DM care and actual everyday care. For example, one study showed that a majority of patients did not achieve target levels of glycated hemoglobin A 1c (HbA 1c ), blood pressure, and blood lipids. 8 This is not unique to the care of diabetic patients. Several studies have shown suboptimal adherence to guidelines both in clinical encounters and in support for self-care. 9, 10 Other studies have highlighted the difficulty achieving significant long-term performance improvement in patients with chronic diseases. 11 Quality improvement (QI) broadly aims at enhancing health care performance in terms of patient and population outcomes, the performance of health care services (ie, quality, safety, and value), and professional development. 12 Quality improvement programs are complex social interventions; to be properly evaluated, the connections between context, content, application, and outcomes need to be understood. 13 Despite widespread application, there is ongoing uncertainty regarding whether quality improvement collaboratives (QICs), or the Breakthrough Collaborative Model, are effective and help improve health care. 14 It remains unclear how best to apply QI principles to services for persons with DM and how much improvement can be expected from such applications. We previously reported on the use of an NQR in a QIC for acute myocardial infarction (AMI) care, with improved performance and patient outcomes, both short and long term. [15] [16] [17] On the assumption that similar effects could be achieved for care of a chronic condition such as diabetes, we undertook a QIC to empower teams, both in primary care and in hospitals, and to systematically improve performance in diabetes care, with support from the NDR. Could we transfer insights and replicate achievements from the AMI experience in services for persons with DM?
The purpose of this study was to evaluate whether and how a QIC, using the online NDR as a tool and measurement system, could influence clinical practice and outcomes for patients with DM. Other studies of the program have evaluated patient-reported outcomes and health economics.
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METHODS
Setting and design of the QIC
Teams from PCUs and IMDs across Sweden were invited to participate in a QIC, which included use of the NDR for monitoring progress. The invitation was sent to all PCUs and IMDs in Sweden, and the teams that first signed up were enrolled in the program. The QIC started in February 2008 and ended in November 2009. The QIC managers guided participating units to form multidisciplinary teams of 3 to 7 people, including physicians, nurses and/or a secretary, assistant nurse, and nutritionist.
Participation in the QIC was conditional based on a number of requirements, expressed in an agreement that the team signed before the project, which stated:
r Management support was needed to ask for results, to allocate time for teams to attend all of the seminars, and to work with improvements at their respective sites.
r The teams must have started to register data from their patients in the NDR regularly before the QIC started.
r Some baseline data had to be collected from the NDR by each unit and brought to the first learning session.
r Every second month during the QIC period, reports taken from the NDR had to be sent to the project leaders.
r The whole team had to make a commitment to participate in all learning sessions. The QIC was modeled on the Breakthrough Collaborative Model, 19, 20 with 4 learning sessions and 2 followup meetings spanning approximately 20 months. At the joint learning sessions, teams received training in QI methods and had time both for teamwork and for sharing experiences among teams (Table 1) . They sought to reach jointly agreed DM quality indicator levels ( Table 2) . Between learning sessions, teams engaged in action periods at home, where they identified problems, formulated action plans, tested changes, and monitored results. Most of the improvements were implemented in the workplace as an integrated part of regular work. During the follow-up phase, participants continued their improvement work, followed up on their results, and reported to the QIC project leaders. This period included 2 follow-up meetings, where teams first presented an interim report and then a final report.
The QIC applied the Model for Improvement, including the PDSA (Plan, Do, Study, Act) cycle. 4, 21 Each team had to answer the following 3 questions: What do we want to accomplish? How will we know that a change is an improvement? What changes can we make that will lead to improvement? Teams assessed success factors and obstacles in an evaluation after each learning session.
The teams were supported by a facilitator before, between, and during the learning sessions. An important factor in the QIC was the use of the online NDR. The facilitator helped the teams learn how to use the NDR and how to get data from the registry. The facilitator also helped the teams learn how to use the different improvement tools.
Study design and data analysis
We used a case study design 22 to describe and evaluate the QIC improvement effort, combining multiple data collection and analysis methods, drawing on the following data sources:
1. Participating team project reports: summaries and lessons learned 2. Teams' evaluations from the QIC learning sessions 3. Quality indicator data from the NDR 4. Project documentation The study was also inspired by an interactive research approach, 23 where the researcher, together with the project leaders, was active in the development of the program and during the learning sessions. This evaluative case study thus combined qualitative and quantitative methods. All teams, except one of the PCUs, submitted a final report on the project, which included a list of changes they had made. We characterized the changes reported by thematic content analysis. 24 The text was condensed into meaning units and then abstracted into themes. To identify and summarize a number of conditions associated with success in the QIC, we thematically analyzed teams' evaluations from each learning session, their project reports, and project documentation.
We analyzed quality indicator data from the NDRblood pressure and low-density lipoprotein (LDL) and HbA 1c levels, mirroring key areas in the national guidelines for DM care-using descriptive statistics over time stratified by participating health care provider units, dividing patients into 3 groups: (a) patients with type 2 DM treated at PCUs (QI-PCU type 2), (b) patients 
Ethical considerations
The study did not handle any data for identifiable individual patients, only aggregate data for different health care organizations. The study concerned improvement efforts undertaken by these organizations, not the actions or performance of individuals. Therefore, this study did not require ethical approval according to Swedish law. To protect participants' privacy, we reported data in such a way that individual patients and participating organizations could not be identified.
RESULTS
Altogether, 23 teams from all over Sweden participated in the project: 16 teams from PCUs and 7 teams from IMDs. The sizes of these units varied. Participating PCUs had between 56 and 462 DM patients, whereas the IMDs had between 220 and 857 DM patients enrolled when the project started. At baseline, patient characteristics were similar at units participating in QIC and non-QIC units in the NDR (Table 3) . Team members remained the same throughout the QIC and participated in all learning seminars, with a few exceptions; for example, when staff changed jobs. In addition, colleagues and coworkers at participating units were also involved in the improvement work.
Teams reported how they used the improvement methods, what changes they made (thematically summarized in Table 4 ), the lessons they learned, and the results (Figures 1-4) . Figure 1 shows that the average HbA 1c levels among patients at QI-PCUs decreased modestly during the QIC whereas HbA 1c levels among patients at non-QIPCUs increased. Among both QI-IMDs and non-QIIMDs, average HbA 1c levels did not improve.
The average systolic blood pressure declined, as intended, among patients with type 2 DM, particularly at QIC units. The average LDL levels for patients at PCUs declined, as intended, with QI-PCUs approaching the national average in period 3, although neither PCUs nor IMDs reached the treatment target level. Among patients at IMDs, average LDL levels declined but with overlapping confidence intervals. Figures 2-4 illustrate, in a cross-sectional manner, the changes in data between the 2 time periods (before and after the intervention) for HbA 1c , systolic blood pressure, and LDL. The same patients were not necessarily observed in both periods.
Very small changes were seen for HbA 1c (Figure 2 ). The QI-PCUs showed a slight improvement; the first and third quartiles were slightly lower in the second period. In general, the 97.5th percentile was lower in the second period, with the exception of non-QI-PCUs. Although the changes were slight, they might be an indication of improvement in patients with the highest HbA 1c levels.
Lower systolic blood pressure was seen in most groups after the QIC (Figure 3) . In all groups, except at non-QI-PCUs, 75% of the patients had blood pressure below 140 mm Hg, with 50% of patients having blood pressure below 130 mm Hg. For QI-PCUs, the median and the third quartile showed an approximately 5-unit decrease in period 2 and a smaller decrease in the first quartile. This is in line with the targeting of patients with the highest values by the intervention. Figure 4 shows that there was a slight decrease in average LDL levels among patients at the QIC units after the QIC. The changes for the rest of the country were small.
The teams whose patients experienced the largest improvements in HbA 1c levels and blood pressure ( Figure 5 ) used similar improvement concepts. The 2 QI-IMD teams with the greatest improvement in HbA 1c levels were the only IMD teams to report that they actively gave their patients information and discussed target levels of HbA 1c with them. They were also the only 2 teams to improve their HbA 1c testing procedure so that results were available at patients' visits. To improve patients' blood pressure, the best QI-IMD teams used the "diabetes profile," a printed copy of each patient's values given to the patient at the visit, to discuss at appointments. They also used documented action plans and individual targets for their patients.
The 3 QI-PCU teams whose patients experienced the largest improvement in HbA 1c levels all changed their way of using the NDR. They sent an information letter before patient visits to help patients prepare. The QI-PCU teams whose patients experienced the largest improvements in blood pressure also used information letters to their patients, which focused on lifestyle questions (eg, diet, physical activity, and smoking habits). They also emphasized the importance of teamwork. For example, they met regularly and discussed results so that the unit would be able to quickly act on them.
The following actions that promoted QIC success, in terms of better performance and sustainable improvement efforts, emerged in our analysis of the teams' final reports, in their evaluations of QIC joint meetings, and in the project documentation:
1. Teamwork, having everyone involved. Teams characterized by strong multidisciplinary teamwork and a workplace culture supportive of improvement were more successful. 2. Review your own data iteratively over time. The data collection routine in the NDR was crucial for the teams; it enabled them to review performance and learn from the results. 3. Analyze and reflect on the results, and discuss what changes to test. Successful teams allocated time to analyzing their data together. 4. Make changes in the work process; test a lot of ideas. More successful teams ran multiple tests of change on a small scale in their daily work using the PDSA cycle. 5. Learn from others. The collaborative improvement framework facilitated learning from others' experiences and encouraged teams to take on good ideas. Teams had time to exchange experiences at each learning session. 6. A structured improvement program and facilitation is helpful. The program with learning sessions gave the teams the time and structure to work with their improvement ideas. Having a QIC facilitator provided support, both at the learning sessions and at visits, for the teams' work settings. 7. Leaders can help by showing interest and asking for results. Teams found it useful when their leaders showed interest and gave them time for improvement work.
DISCUSSION
In this study, we used a previously tested model that had been successful in QICs for the acute phase of AMI. [15] [16] [17] We used it to improve the long-term process of treating patients for the chronic diabetes disease. While it was possible to attract clinical teams to join and complete this diabetes QIC, it was less straightforward to achieve substantial performance improvement, measured as changes in risk factors and not as changes in processes. Yet, we did identify a number of success factors, and 2 of the 3 risk factors measured in this study improved over time. In contrast to previous studies of collaborative learning, which involved different approaches to improvement and showed variable results for DM care, 11, [25] [26] [27] this study included patients with both type 1 and 2 DM in both IMDs and PCUs. We evaluated performance according to 3 key risk factors in the NDR and compared participating units with the rest of the country for more than 30 months, thus covering the vast majority of people treated for DM across Sweden. Few other studies of QIC have had such a long followup period and such broad national comparisons. 28 The intervention occurred between 2008 and 2009, with a long follow-up period, and the changes were informed by the existing guideline. The large trials ACCORD and ADVANCE 29, 30 that were published in 2008 could not confirm a beneficial effect of intensive glucose control on macrovascular events. As a result, Swedish and international treatment guidelines recommended a more personalized treatment strategy that focused on intensive glucose control in patients with relatively short diabetes duration and without previous cardiovascular diseases and less strict control in high-risk patients. This has influenced the HbA 1c trend in Sweden and may partly explain our findings regarding impact on HbA 1c levels. Otherwise, there has not been any major change in guidelines during the follow-up period. Therefore, the fundamental research question remains: How and why might QICs work? Here, our results including success factors add to the evolving knowledge base.
Participating teams were included on the basis of voluntary self-selection on a first-come, first-served basis. The goal was 20 teams, but when 3 more teams wanted to participate, we decided to include them as well. More programs were later implemented to meet the needs of teams that wanted to participate. Therefore, the teams included in the study may not be representative of all service providers across the country. The baseline data showed, however, that QIC units started at a level of performance similar to that of the rest of the units in the NDR.
The QIC participants showed clinically significant performance improvement in blood pressure and LDL measurements compared with the rest of the country according to the NDR data, even if their patients in the aggregate did not reach the guideline targets (apart from systolic blood pressure for patients with type 1 DM, which remained below the target of 130 mm Hg; Figure 1 ). The large UK Prospective Diabetes Study 31 showed that several risk factors need to be addressed for patients with diabetes. This is mirrored by the 5-year risk model for both type 1 and 2 diabetes. 32, 33 The risk model shows that several factors increase the risk of diabetic complications and cardiovascular disease within the next 5 years. In our study, LDL and blood pressure showed the most improvement. We argue that improvement of 2 of 3 risk factors is a good result, considering that the improvement work was carried out without any extra resources. The changes made by the teams concerned improved work practices and procedures. They sought to reach the treatment targets by more active treatment of their patients and improved clinical routines. Although the changes were very modest, the data indicate improvement in HbA 1c levels among patients with high values at baseline ( Figure  2) , as has been shown previously. 34 HbA 1c levels deteriorated in the NDR population as a whole during the QIC, with the HbA 1c levels of patients of the QIC teams the same as those of the rest of the country. As noted earlier, there is an ongoing debate about HbA 1c targets and how low they should be. According to NDR data, average HbA 1c levels for both type 1 and 2 DM have been rising slowly in Sweden since 2007, until 2013 when there was a trend break in terms of HbA 1c , with improvement particularly among patients with high levels. Change in HbA 1c levels probably requires more patient interaction/education. Patients need to take a greater responsibility for their care, 35 which was not sufficiently tested as part of this QIC, even if many teams performed some actions in this area. Some teams did improve their patient population's aggregated HbA 1c level. Even if their improvements were limited, they point to teamwork, engaging the patient, and changing routines in taking care of patients as important for success.
The study was set in everyday care, not in settings selected on the basis of narrow criteria. The work was carried out by participating teams as part of their regular work. No dedicated funding was provided to the teams for participating in the QIC. The different themes of improvement activities mainly focused not only on changes in practice, guidelines, and improved teamwork but also on how to involve patients in their own care. No extra efforts were required of participating teams to collect data for the study; they already used the NDR as part of their regular clinical practice, although several teams improved their data registration and review practices as part of the QIC. Such a computerized system, to support frontline clinical process management and improvement work and at the same time provide data for aggregated annual reports and nationwide comparisons, is important for achieving improvement. 5, 25 The NDR, described as the most comprehensive electronic, population-based NDR in the world, 36 includes almost all units and DM patients in Sweden. The NDR provides teams and leaders with the opportunity to continuously monitor adherence to national guidelines for DM care and compare their performance with that of the rest of the country. A lack of quality indicator data has proven to be a limitation in many other studies of QI. 28, 37 The NDR allowed us to assess and compare data on performance among both participating units and all non-QIC units in the NDR as a whole.
The present project has formed the foundation for a structured approach to continuous improvement connected to the use of an NQR. Considering the widespread use of QICs, deeper investigation is warranted to clarify what aspects of QICs work for whom, and why, in different contexts 13, 19, [38] [39] [40] and to ensure sustainability. 41, 42 A more profound understanding could enhance improvement work that employs quality registers in Sweden and elsewhere.
Considering all of the collected material, we have evidence that structure in the program was important to the QIC for both AMI and DM. Moreover, the fact that the whole team focused on the same issue made it possible to share experiences. In the evaluation of each program, the opportunity to share ideas and the results of tested ideas was pointed out as very important and useful by the participants. The structure of the content in the QIC (eg, use of the PDSA wheel) also made it possible for teams to have structure and support in the change process. The difficult part turned out to be the application of new ideas and suggestions, which required active work at the participants' respective clinics. The results and lessons learned described in the final reports indicate that improvement work takes time. In contrast to the QIC for AMI, [15] [16] [17] the QIC for the chronic condition of diabetes was more challenging, because of the required long-term follow-up. HbA 1c levels in patients tend to increase with disease duration. 1, 31 In this study, we followed the same patients during the whole QIC. In the AMI QIC, most changes focused on medication or clinical tests, whereas in the DM QIC, most of the changes required improved performance in terms of clinical indicators concerned with supporting patients both in self-care and in making lifestyle changes. This may be a bigger challenge that will take longer to address successfully. If so, this could help explain the differences in the impact of the AMI and DM QICs. Further work will need to address the challenges specific to chronic conditions such as DM.
The NDR did not enable teams to track process indicators, which likely would have helped them in guiding continuous improvement efforts. This is particularly challenging for a chronic condition such as DM, where practice changes may have an impact on outcomes far into the future. In our studies of the AMI QIC, [15] [16] [17] several process measures were available and amenable to improvement; for example, the proportion of patients who received angiotensin-converting enzyme inhibitors before discharge.
In this study, we were unable to link particular changes made by different teams to specific outcomes. Instead, we assessed changes in the 3 selected quality indicators associated with the QIC as a whole. Evaluations of the most successful PCU and IMD teams did, however, show that they had in common certain changes that they had applied.
While the effectiveness of improvement collaboratives has been questioned, 14, 39 this study shows that this QIC enabled some teams to accomplish clinically meaningful improvement in DM care and their patients' risk status but that major impact was elusive. Further research is needed to further unpack the "black box" of improvement. 12, 13 Still, the 7 actions promoting QIC success that emerged in this study and similar in other studies 43, 44 can support teams and leaders who are planning new QICs.
CONCLUSION
Using the online NDR as a tool and measurement system in a QIC, the teams in this study significantly improved performance with respect to 2 national DM guideline targets among their patients compared with other units in the NDR. Our findings suggest that the QIC helped teams close the gap between ordinary clinical practice and evidence-based guidelines and contributed better care and better clinical outcomes. This should, in turn, yield better quality of life for people with DM. At the same time, the impact was limited regarding HbA 1c levels. This point to challenges in the improvement of care for patients with DM, with its substantial reliance on self-care, compared with care for patients with AMI, for whom more of the care is directly related to caregiver actions during hospitalization. At the same time, this study revealed general success factors that could be the foundation for QIC in different contexts.
